[The apolipoprotein E genotype and Down's syndrome]

Area of Science:

• Neuroscience
• Genetics
• Gerontology

Background:

• Down syndrome is associated with an increased risk of early-onset Alzheimer-type dementia.
• The apolipoprotein E (apo E) epsilon 4 allele is a known genetic risk factor for late-onset Alzheimer disease.
• Understanding genetic factors in Down syndrome-related dementia is crucial for early diagnosis and intervention.

Purpose of the Study:

• To investigate the distribution of apolipoprotein E (apo E) genotypes in individuals with Down syndrome.
• To determine if the apo E epsilon 4 allele influences the manifestation of Alzheimer disease in this population.

Main Methods:

• Genotyping of apolipoprotein E (apo E) was performed on 21 patients with Down syndrome using molecular analysis.
• Statistical comparison of apo E genotype frequencies between the Down syndrome cohort and the general population.

Main Results:

• The most common genotype in the studied Down syndrome population was epsilon 3/epsilon 3 (76%).
• Genotypes epsilon 3/epsilon 4 and epsilon 2/epsilon 3 were found in 9% of individuals.
• No individuals were homozygous for the epsilon 4 allele.
• The distribution of apo E genotypes in the Down syndrome group was similar to that of the general population.

Conclusions:

• The apolipoprotein E (apo E) genotype distribution does not significantly differ between individuals with Down syndrome and the general population.
• The presence of the apo E epsilon 4 allele does not appear to influence the development of Alzheimer disease in individuals with Down syndrome.
• Further research may explore other genetic or environmental factors contributing to dementia in Down syndrome.